Monocolonization of germ-free mice with bacteroides fragilis protects against dextran sulfate sodium-induced acute colitis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chiu, Chien Chao ^a   Ching, Yung Hao ^b   Wang, Yu Chih ^c   Liu, Ju Yun ^d,e   Li, Yen Peng ^d   Huang, Yen Te ^d   Chuang, Hsiao Li ^d  

^a NATIONAL TAIWAN SPORT UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL APPLIED RESEARCH LABORATORIES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; HEMOGLOBIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; BODY WEIGHT; CELL INFILTRATION; COLITIS; COLON; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME ACTIVITY; ERYTHROCYTE COUNT; GENE EXPRESSION; GERMFREE ANIMAL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; IMMUNE RESPONSE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; OCCULT BLOOD; SPLEEN WEIGHT; SURVIVAL; THROMBOCYTE COUNT; ACUTE DISEASE; ANIMAL; BACTERIAL COUNT; BLOOD; BLOOD CELL COUNT; C57BL MOUSE; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; KAPLAN MEIER METHOD; METABOLISM; MICROBIOLOGY; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ANIMALS; BACTEROIDES FRAGILIS; BLOOD CELL COUNT; COLITIS; COLON; COLONY COUNT, MICROBIAL; DEXTRAN SULFATE; GENE EXPRESSION REGULATION; GERM-FREE LIFE; INFLAMMATION; KAPLAN-MEIER ESTIMATE; MALE; MICE, INBRED C57BL; PEROXIDASE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84902251372     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/675786     Document Type: Article

References (30)

1. Podolsky D. K., Medical progress: inflammatory bowel disease. The New England Journal of Medicine 1991 325 14 1008 1016 2-s2.0-0026415351 10.1056/NEJM199110033251406
2. Ohkusa T., Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and change in intestinal microflora. Nihon Shokakibyo Gakkai Zasshi 1985 82 5 1327 1336 2-s2.0-0021800129
3. Monteleone G., Pallone F., MacDonald T. T., Emerging immunological targets in inflammatory bowel disease. Current Opinion in Pharmacology 2011 11 6 640 645 2-s2.0-82255175757 10.1016/j.coph.2011.09.013
4. Mahida Y. R., Wu K., Jewell D. P., Enhanced production of interleukin 1- β by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989 30 6 835 838 2-s2.0-0024344814
5. Atreya R., Mudter J., Finotto S., Müllberg J., Jostock T., Wirtz S., Schütz M., Bartsch B., Holtmann M., Becker C., Strand D., Czaja J., Schlaak J. F., Lehr H. A., Autschbach F., Schürmann G., Nishimoto N., Yoshizaki K., Ito H., Kishimoto T., Galle P. R., Rose-John S., Neurath M. F., Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nature Medicine 2000 6 5 583 588 2-s2.0-18344410191 10.1038/75068
6. Komatsu M., Kobayashi D., Saito K., Furuya D., Yagihashi A., Araake H., Tsuji N., Sakamaki S., Niitsu Y., Watanabe N., Tumor necrosis factor- α in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clinical Chemistry 2001 47 7 1297 1301 2-s2.0-0034956578
7. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003 52 1 65 70 2-s2.0-0037216498 10.1136/gut.52.1.65
8. Mazmanian S. K., Round J. L., Kasper D. L., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008 453 7195 620 625 2-s2.0-44449106055 10.1038/nature07008
9. Ogawa A., Andoh A., Araki Y., Bamba T., Fujiyama Y., Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clinical Immunology 2004 110 1 55 62 2-s2.0-0842324613 10.1016/j.clim.2003.09. 013
10. O'Connor W. Jr., Kamanaka M., Booth C. J., Town T., Nakae S., Iwakura Y., Kolls J. K., Flavell R. A., A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nature Immunology 2009 10 6 603 609 2-s2.0-65749091607 10.1038/ni.1736
11. Hansen J. J., Huang Y., Peterson D. A., Goeser L., Fan T.-J., Chang E. B., Sartor R. B., The colitis-associated transcriptional profile of commensal Bacteroides thetaiotaomicron enhances adaptive immune responses to a bacterial antigen. PLoS ONE 2012 7 8 2-s2.0-84864566664 10.1371/journal.pone.0042645 e42645
12. Hakansson A., Tormo-Badia N., Baridi A., Xu J., Molin G., Hagslätt M. L., Karlsson C., Jeppsson B., Cilio C. M., Ahrne S., Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clinical and Experimental Medicine 2014 10.1007/s10238-013-0270-5
13. Mazmanian S. K., Liu C. H., Tzianabos A. O., Kasper D. L., An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005 122 1 107 118 2-s2.0-22144490199 10.1016/j.cell.2005. 05.007
14. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences of the United States of America 2010 107 27 12204 12209 2-s2.0-77954738601 10.1073/pnas.0909122107
15. Hudcovic T., Kozáková H., Kolínská J., Štěpánková R., Hrnčíř T., Tlaskalová-Hogenová H., Monocolonization with Bacteroides ovatus protects immunodeficient SCID mice from mortality in chronic intestinal inflammation caused by long-lasting dextran sodium sulfate treatment. Physiological Research 2009 58 1 101 110 2-s2.0-66549102005
16. Uronis J. M., Mühlbauer M., Herfarth H. H., Rubinas T. C., Jones G. S., Jobin C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS ONE 2009 4 6 2-s2.0-67650299380 10.1371/journal.pone.0006026 e6026
17. Kitajima S., Morimoto M., Sagara E., Shimizu C., Ikeda Y., Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Experimental Animals 2001 50 5 387 395 2-s2.0-0035489567 10.1538/expanim.50.387
18. Geier M. S., Butler R. N., Giffard P. M., Howarth G. S., Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. International Journal of Food Microbiology 2007 114 3 267 274 2-s2.0-33847138191 10.1016/j.ijfoodmicro.2006. 09.018
19. Osman N., Adawi D., Ahrné S., Jeppsson B., Molin G., Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Digestive Diseases and Sciences 2008 53 9 2464 2473 2-s2.0-50249139552 10.1007/s10620-007-0174-x
20. Kokešová A., Frolová L., Kverka M., Sokol D., Rossmann P., Bártová J., Tlaskalová-Hogenová H., Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice. Folia Microbiologica 2006 51 5 478 484 2-s2.0-33751342532 10.1007/BF02931595
21. Heilpern D., Szilagyi A., Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, prebiotics and synbiotics. Reviews on Recent Clinical Trials 2008 3 3 167 184 2-s2.0-54049101671 10.2174/157488708785700302
22. Teran-Ventura E., Aguilera M., Vergara P., Martínez V., Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats. Jounnal of Crohns and Colitis 2014 10.1016/j.crohns.2014.02.001
23. Mähler M., Bristol I. J., Leiter E. H., Workman A. E., Birkenmeier E. H., Elson C. O., Sundberg J. P., Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. The American Journal of Physiology 1998 274 3, part 1 G544 G551 2-s2.0-0031945843
24. Bylund-Fellenius A. C., Landstrom E., Axelsson L. G., Midtvedt T., Experimental colitis induced by dextran sulphate in normal and germfree mice. Microbial Ecology in Health and Disease 1994 7 4 207 215 2-s2.0-0028011152
25. Dai C., Zheng C.-Q., Meng F.-J., Zhou Z., Sang L.-X., Jiang M., VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF- B pathway in rat model of DSS-induced colitis. Molecular and Cellular Biochemistry 2013 374 1-2 1 11 2-s2.0-84871986920 10.1007/s11010-012-1488-3
26. Hansen J. J., Holt L., Sartor R. B., Gene expression patterns in experimental colitis in IL-10-deficient mice. Inflammatory Bowel Diseases 2009 15 6 890 899 2-s2.0-67650225283 10.1002/ibd.20850
27. Cross R. K., Wilson K. T., Nitric oxide in inflammatory bowel disease. Inflammatory Bowel Diseases 2003 9 3 179 189 2-s2.0-0038392976 10.1097/00054725-200305000-00006
28. Hokari R., Kato S., Matsuzaki K., Kuroki M., Iwai A., Kawaguchi A., Nagao S., Miyahara T., Itoh K., Sekizuka E., Nagata H., Ishii H., Miura S., Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radical Biology and Medicine 2001 31 2 153 163 2-s2.0-0035879845 10.1016/S0891-5849(01)00565-2
29. Seril D. N., Liao J., Yang G.-Y., Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis. Molecular Carcinogenesis 2007 46 5 341 353 2-s2.0-34248396797 10.1002/mc.20282
30. Jadhav S. R., Shandilya U. K., Kansal V. K., Exploring the ameliorative potential of probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on dextran sodium sulphate induced colitis in mice. Journal of Dairy Research 2013 80 1 21 27 2-s2.0-84872463534 10.1017/S0022029912000684